These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20347273)

  • 41. Influence of the dosing interval on prolactin release after remoxipride.
    Movin-Osswald G; Hammarlund-Udenaes M; Von Bahr C; Eneroth P; Walton-Bowen K
    Br J Clin Pharmacol; 1995 May; 39(5):503-10. PubMed ID: 7669486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The TRH-stimulation test in DSM-III personality disorder.
    Kavoussi RJ; Coccaro EF; Klar H; Lesser J; Siever LJ
    Biol Psychiatry; 1993 Aug; 34(4):234-9. PubMed ID: 8399820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Separation of positive and disorganization symptoms by prolactin response to 12.5 μg intravenous TRH.
    Spoov J; Bredbacka PE; Stenman UH
    Schizophr Res; 2020 Jan; 215():449-450. PubMed ID: 31662234
    [No Abstract]   [Full Text] [Related]  

  • 44. Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia.
    Albayrak Y; Beyazyüz M; Beyazyüz E; Kuloğlu M
    Nord J Psychiatry; 2014 Jul; 68(5):341-6. PubMed ID: 24094029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laboratory assessment of prolactin status.
    Cowden EA; Ratcliffe WA; Beastall GH; Ratcliffe JG
    Ann Clin Biochem; 1979 May; 16(3):113-21. PubMed ID: 117734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
    Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
    Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolactin responses to domperidone in chronic schizophrenia.
    Nerozzi D; Magnani A; Dastoli C; Ferri E; Capesciotti G; Antonozzi I; Frajese G; Meltzer HY
    Psychiatry Res; 1992 May; 42(2):159-69. PubMed ID: 1631251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
    Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
    Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration.
    Brambilla F; Aguglia E; Massironi R; Maggioni M; Grillo W; Castiglioni R; Catalano M; Drago F
    Neuropsychobiology; 1986; 15(3-4):114-21. PubMed ID: 3097570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Noradrenergic and dopaminergic interrelation in schizophrenia.
    Brambilla F; Marini S; Saito A; Fassone G; Picardi A; Nerozzi D; Pancheri P
    Psychiatry Res; 1994 Sep; 53(3):231-42. PubMed ID: 7870845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia.
    Angelopoulos EK; Markianos M; Daskalopoulou EG; Hatzimanolis J; Tzemos J
    Psychiatry Res; 2002 May; 110(1):9-17. PubMed ID: 12007589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methodological considerations regarding the association of Stroop and verbal fluency performance with the symptoms of schizophrenia.
    Woodward TS; Ruff CC; Thornton AE; Moritz S; Liddle PF
    Schizophr Res; 2003 Jun; 61(2-3):207-14. PubMed ID: 12729872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum prolactin response to thyrotropin-releasing hormone during status epilepticus.
    Lindbom U; Tomson T; Nilsson BY; Andersson DE
    Seizure; 1993 Sep; 2(3):235-9. PubMed ID: 8162388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prolactin response to TRH in patients with idiopathic delayed puberty].
    Mauri R; Resentini M; Lissoni P; Morabito F
    Minerva Pediatr; 1984 Oct; 36(20):1013-6. PubMed ID: 6442393
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of neuroleptics on serum prolactin in schizophrenic patients.
    Meltzer HY; Fang VS
    Arch Gen Psychiatry; 1976 Mar; 33(3):279-86. PubMed ID: 1259521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current status of the rat prolactin releasing factor.
    Shin SH; Papas S; Obonsawin MC
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2036-43. PubMed ID: 3123042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Studies on the hypothalamic-pituitary dopaminergic system in Parkinson's disease and spinocerebellar degeneration. Response to TRH and sulpiride].
    Joshita Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):59-66. PubMed ID: 3106541
    [No Abstract]   [Full Text] [Related]  

  • 58. Differential prolactin responses to haloperidol and TRH in normal adult men.
    Hays SE; Rubin RT
    Psychoneuroendocrinology; 1981; 6(1):45-52. PubMed ID: 6787635
    [No Abstract]   [Full Text] [Related]  

  • 59. Hormones, dopamine receptors and schizophrenia.
    Meltzer HY; Busch D; Fang VS
    Psychoneuroendocrinology; 1981; 6(1):17-36. PubMed ID: 7244055
    [No Abstract]   [Full Text] [Related]  

  • 60. Failing Memory in Nonaffective Psychosis and Prolactin Response to 12.5 µg i.v. TRH.
    Spoov J; Bredbacka PE
    Pharmacopsychiatry; 2021 Sep; 54(5):246-247. PubMed ID: 33979866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.